Search Results

There are 32195 results for: content related to: Reply

  1. You have free access to this content
    The Pharmacology and Therapeutic Use of Dabigatran Etexilate

    The Journal of Clinical Pharmacology

    Volume 53, Issue 1, January 2013, Pages: 1–13, Spinler Sarah

    Article first published online : 24 JAN 2013, DOI: 10.1177/0091270011432169

  2. Dabigatran etexilate: What do hospitalists need to know?

    Journal of Hospital Medicine

    Volume 7, Issue 3, March 2012, Pages: 262–269, Amer Zeidan, Bishoy Faltas and Michael Streiff

    Article first published online : 29 NOV 2011, DOI: 10.1002/jhm.996

  3. A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 599–609, Paul K. L. Chin, Daniel F. B. Wright, David M. Patterson, Matthew P. Doogue and Evan J. Begg

    Article first published online : 21 AUG 2014, DOI: 10.1111/bcp.12364

  4. Dabigatran Etexilate in Clinical Practice: Confronting Challenges to Improve Safety and Effectiveness

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 12, December 2011, Pages: 1232–1249, Dr. Michael P. Gulseth, Dr. Ann K. Wittkowsky, Mr. John Fanikos, Dr. Sarah A. Spinler, Dr. William E. Dager and Dr. Edith A. Nutescu

    Article first published online : 20 JAN 2012, DOI: 10.1592/phco.31.12.1232

  5. Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic Diseases

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 11, November 2008, Pages: 1354–1373, Dr. Brooke E. Baetz and Dr. Sarah A. Spinler

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.28.11.1354

  6. You have free access to this content
    Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin

    British Journal of Clinical Pharmacology

    Volume 74, Issue 3, September 2012, Pages: 490–500, Sebastian Härtter, Michael Koenen-Bergmann, Ashish Sharma, Gerhard Nehmiz, Ute Lemke, Wolfgang Timmer and Paul A. Reilly

    Article first published online : 6 AUG 2012, DOI: 10.1111/j.1365-2125.2012.04218.x

  7. Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 555–565, Dr Joachim Stangier, Dr Bengt I. Eriksson, Dr Ola E. Dahl, Dr Lennart Ahnfelt, Dr Gerhard Nehmiz, Hildegard Stähle, Dr Karin Rathgen and Dr Robbyna Svärd

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270005274550

  8. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 243–250, Dr Joachim Stangier, Ms Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth, Dr Kathrin Reseski and Dr Thomas Körnicke

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010393342

  9. Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 630–638, Paul K. L. Chin, David M. Patterson, Mei Zhang, Berit P. Jensen, Daniel F. B. Wright, Murray L. Barclay and Evan J. Begg

    Article first published online : 21 AUG 2014, DOI: 10.1111/bcp.12366

  10. You have free access to this content
    Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation

    Clinical Cardiology

    Volume 37, Issue 1, January 2014, Pages: 32–47, Irene Savelieva and A. John Camm

    Article first published online : 19 NOV 2013, DOI: 10.1002/clc.22204

  11. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment

    The Journal of Clinical Pharmacology

    Volume 48, Issue 12, December 2008, Pages: 1411–1419, Dr Joachim Stangier, Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth and Dr Kasra Shakeri-Nejad

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008324179

  12. An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis

    The Journal of Clinical Pharmacology

    Volume 54, Issue 8, August 2014, Pages: 901–909, Jo-Anne S. Wilson, Kerry B. Goralski, Steven D. Soroka, Matthew Morrison, Paula Mossop, Lekha Sleno, Yan Wang and David R. Anderson

    Article first published online : 28 MAY 2014, DOI: 10.1002/jcph.335

  13. You have free access to this content
    Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong

    Clinical Cardiology

    Volume 35, Issue 12, December 2012, Pages: E40–E45, Jason C. S. Ho, Andy M. Chang, Bryan P. Yan, Cheuk Man Yu, Yat Yin Lam and Vivian W. Y. Lee

    Article first published online : 25 OCT 2012, DOI: 10.1002/clc.22069

  14. The Use of Dabigatran Immediately After Atrial Fibrillation Ablation

    Journal of Cardiovascular Electrophysiology

    Volume 23, Issue 3, March 2012, Pages: 264–268, ROGER A. WINKLE, R. HARDWIN MEAD, GREGORY ENGEL, MELISSA H. KONG and ROB A. PATRAWALA

    Article first published online : 28 SEP 2011, DOI: 10.1111/j.1540-8167.2011.02175.x

  15. You have free access to this content
    Acute Stroke Management in Patients Taking Dabigatran

    CNS Neuroscience & Therapeutics

    Volume 18, Issue 8, August 2012, Pages: 616–622, Raf Brouns, Robbert-Jan Van Hooff, Ann De Smedt, Maarten Moens, Sylvie De Raedt, Maarten Uyttenboogaart, Gert-Jan Luijckx, Kristin Jochmans and Jacques De Keyser

    Article first published online : 25 APR 2012, DOI: 10.1111/j.1755-5949.2012.00329.x

  16. Protocol in managing oral surgical patients taking dabigatran

    Australian Dental Journal

    Volume 59, Issue 3, September 2014, Pages: 296–301, O Breik, A Cheng, PJ Sambrook and AN Goss

    Article first published online : 30 JUL 2014, DOI: 10.1111/adj.12199

  17. Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation

    Journal of the American Association of Nurse Practitioners

    Katie A. Scott and Karen A. Amirehsani

    Article first published online : 25 JUL 2014, DOI: 10.1002/2327-6924.12161

  18. You have free access to this content
    Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 4, April 2010, Pages: 790–798, C. T. AMMOLLO, F. SEMERARO, F. INCAMPO, N. SEMERARO and M. COLUCCI

    Article first published online : 17 JAN 2010, DOI: 10.1111/j.1538-7836.2010.03739.x

  19. New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 10, October 2011, Pages: 975–1016, Estella M. Davis, Kathleen A. Packard, Jon T. Knezevich and Jennifer A. Campbell

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.31.10.975

  20. You have free access to this content
    REVIEW: Atrial Fibrillation and Dabigatran: Has the Time Come To Use New Anticoagulants?

    Cardiovascular Therapeutics

    Volume 28, Issue 5, October 2010, Pages: 295–301, Carlos Escobar, Vivencio Barrios and David Jimenez

    Article first published online : 16 AUG 2010, DOI: 10.1111/j.1755-5922.2010.00216.x